CARVANA CO. vs CVS HEALTH CORPORATION, two Retail stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVNA and CVS diverge most: on return on assets, CVNA reads 10.8% and CVS reads 1.2%; on net margin, CVNA reads 6.3% and CVS reads 0.7%. The rest of the comparable metrics sit closer together. What CVS's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVNA | CVS |
|---|---|---|
| Price | $63.73 | $86.18 |
| Market cap | $47.2B | $110.9B |
| Sector | Retail | Retail |
| Stage | Growth | Mature |
| P/E | — | 22.7 |
| P/B | 9.18 | 1.39 |
| P/S | 1.88 | 0.27 |
| EV/EBITDA | 22.1 | 12.6 |
| Revenue growth | +54.2% | +7.3% |
| Gross margin | 18.8% | — |
| Operating margin | 9.2% | 4.4% |
| Net margin | 6.3% | 0.7% |
| Return on equity | 30.5% | 3.7% |
| Return on assets | 10.8% | 1.2% |
| Return on invested capital | 17.1% | 4.4% |
| FCF yield | 2.0% | 10.6% |
| Dividend yield | — | 3.1% |
| Debt / equity | 1.01 | 0.77 |
| Current ratio | 3.93 | 0.87 |
| Altman Z (solvency) | 5.43 | 2.39 |
| Piotroski F (quality) | 6 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.